Fibrinolytic components in nasal mucosa and nasal secretion

Histochemistry and Cell Biology

Volumn 110, Issue 5, 1998, Pages 449-455

  Yasuda, Toyotoshi ^a   Sakata, Yoichi ^a   Madoiwa, Seiji ^b   Mimuro, Jun ^b   Matsuda, Michio ^b   Kitamura, Ken ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE MUCOSA; NOSE SECRETION; PRIORITY JOURNAL; PROTEIN DETERMINATION;

AUTORADIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN; FIBRINOLYSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NASAL MUCOSA; PLASMINOGEN ACTIVATOR INHIBITOR 1; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031753488     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004180050306     Document Type: Article

References (26)

1. Åkerlund A, Greiff L, Andersson M, Bende M, Alkner U, Persson CGA (1993) Mucosal exudation of fibrinogen in coronavirus-induced common colds. Acta Otolaryngol (Stockh) 113:642-648
2. Breeze RG Wheeldon EB (1977) The cells of the pulmonary airways. Am Rev Respir Dis 116:705-777
3. Bugge TH, Flick MD, Danton MJS, Daugherty CC, Romer J, Dano K, Carmeliet P, Collen D, Degen FL (1996a) Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activtor. Proc Natl Acad Sci USA 93:5899-5904
4. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC. Danton MJ, Degen JL (1996b) Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87:709-719
5. Carmeliet P, Collen D (1995) Gene targeting and gene transfer studies of th eplasminogen/plasmin system:implications in thrombosis, hemostasis, neointima formation, and atherosclerosis. FASEB 9:934-938
6. Carmeliet P, Moons L, Pioplis V, Plow E, Collen D (1997) Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J Clin Invest 99:200-208
7. Danf K, Andreassen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985) Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139-266
8. Glod LI, Tostagno A, Frangione B, Passalaris T (1992) Localization of the cleavage sites on fibronectin following digestion by urokinase. J. Cell Biochem 50:441-452.
9. Hamaguchi Y, Ohi M, Sakakura Y, Miyoshi Y (1985) Purification and characterizaton of tissue-type plasminogen activator in maxillary mucosa with chronic inflammation. Thromb Haemost 54:485-489
10. Jafek BW (1983) Ultrastructure of human nasal mucosa. Laryngoscope 93:1576-1599
11. Jensen PJ, Rodeck U (1993) Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF-a/EGF receptor. J Cell Physiol 155:133-139
12. Kawano T, Morimoto K, Uemura Y (1968) Urokinase inhibitor in human placenta. Nature 217:253-254
13. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
14. Liu YX, Peng XR, Ny T (1991) Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type 1 and tissue-type plasminogen activator in the rat ovary during gonadotropin-induced ovulation. Eur J Biochem 195: 549-555
15. Loskutoff DJ, Sadway M, Mimuro J (1989) Type 1 plasminogen activator inhibitor. Prog Hemost Thrombos 9:87-115
16. Manchanda N, Schwartz BS (1995) Interaction of single-chain urokinase and plasminogen activator inhibitor type 1. J Biol Chem 270:20032-20035
17. Raphael GD, Druce HM, Wright, RH, Kaliner M (1988) Pathophysiology of rhinitis. I. Assessment of the source of protein in induced nasal secretion. Am Rev Respir Dis 138:413-420
18. Sadwey M, Loskutoff DJ (1991)Regulation of murine plasminogen activator inhibitor 1 gene expression in vivo. Tissue specificity and induction by lipopolysacharide, tumor necrosis factor-a, and transforming growth factor-b. J Clin Invest 88: 1346-1353
19. Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ (1985) Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 82:11221-11225
20. Sakata Y, Okada M, Noro A, Matsuda M (1988) Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells. J Biol Chem 263:1960-1969
21. Sakata Y, Murakami T, Noro A, Mori K, Matsuda M (1991) The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia. Blood 77:1949-1957
22. Schneiderman J, Bordin GM, Engelberg I, Adar R, Seifert W, Thinnes T, Bernstein EF, Dilley RB, Loskutoff DJ (1995) Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. J Clin Invest 96:639-645
23. Sprengers ED, Kluft C (1987) Plasminogen activator inhibitors. Blood 69:381-387
24. Tachibana M, Morioka H, Machine M, Tanimura F, Mizukoshi O (1986) Amylase secretion by nasal glands. Ann Otol Rhinol Laryngol 95:284-287
25. Wakabayashi K, Sakata Y, Aoki N (1986) Conformation-specific monoclonal antibodies to the calcium-induced structure of protein C. J Biol Chem 26:11097-11105
26. Yamashiro Y, Nakamura M, Huang GW, Kosugi T (1992) Presence of urokinase type plasminogen activator in tissue extracts of antrochoanal polyp. Laryngoscope 102:1049-1052